InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.
From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of ...
Researchers from the Tanenbaum group at the Hubrecht Institute have developed a new microscopy technique to observe how ...
GlobalData on MSN14d
HHS awards $590m to Moderna for mRNA ‘flu vax developmentModerna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...
Researchers from the Tanenbaum group at the Hubrecht Institute have developed a new microscopy technique to observe how ribosomes function in cells. With this method, they can monitor individual ...
Its mRNA technology could allow the firm to compete ... thanks to similarities to covid vaccines. For example, Moderna aims to launch a combination covid/influenza vaccine in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback